S. Danoff

R. Hales, D. Ettinger, L. Yarmus, 2019, Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer.

Pneumonitis in Non–Small Cell Lung Cancer Patients Receiving Immune Checkpoint Immunotherapy: Incidence and Risk Factors

C. Lin, R. Hales, D. Ettinger, 2018, Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer.

A scoping review of palliative care outcome measures in interstitial lung disease

M. Eakin, S. Mathai, B. Seth, 2021, European Respiratory Review.

COUNTERPOINT: Should Transbronchial Cryobiopsies Be Considered the Initial Biopsy of Choice in Patients With a Possible Interstitial Lung Disease? No.

L. Yarmus, S. Danoff, 2019, Chest.

Collecting patient preference information using a Clinical Data Research Network: demonstrating feasibility with idiopathic pulmonary fibrosis

J. Bridges, I. Hollin, S. Danoff, 2019, Patient preference and adherence.

Toward understanding patient experience in idiopathic pulmonary fibrosis

S. Danoff, 2017, European Respiratory Journal.

Thalidomide inhibits the intractable cough of idiopathic pulmonary fibrosis

M. Horton, N. Lechtzin, S. Danoff, 2008, Thorax.

Predictors of progression in systemic sclerosis patients with interstitial lung disease

Sindhu R. Johnson, V. Cottin, C. Denton, 2020, European Respiratory Journal.

The phenotype of myositis patients with anti-Ku autoantibodies.

A. Mammen, J. Albayda, T. Lloyd, 2021, Seminars in arthritis and rheumatism.

Muscular and extramuscular features of myositis patients with anti-U1-RNP autoantibodies

A. Mammen, J. Albayda, I. Pinal-Fernandez, 2019, Neurology.

Exacerbations in Idiopathic Pulmonary Fibrosis Triggered by Pulmonary and Nonpulmonary Surgery: A Case Series and Comprehensive Review of the Literature

S. Danoff, A. P. Ruhl, Abhijeet Ghatol, 2012, Lung.

Clinical profile of anti-PL-12 autoantibody. Cohort study and review of the literature.

S. Sahn, C. Oddis, S. Danoff, 2009, Chest.

Microscopic polyangiitis presenting as a "pulmonary-muscle" syndrome: is subclinical alveolar hemorrhage the mechanism of pulmonary fibrosis?

J. Stone, F. Askin, S. Danoff, 2007, Arthritis and rheumatism.

Comparison of Forceps, Cryoprobe, and Thoracoscopic Lung Biopsy for the Diagnosis of Interstitial Lung Disease − The CHILL Study

M. Wahidi, L. Yarmus, T. Colby, 2021, Respiration.

Before Freezing Out Cryobiopsy, We Need to Thaw Out Flaws in the Diagnosis of Interstitial Lung Disease

M. Wahidi, L. Yarmus, J. Hetzel, 2019, American journal of respiratory and critical care medicine.

The ILD-GAP risk prediction model performs poorly in myositis-associated interstitial lung disease.

A. Mammen, J. Albayda, I. Pinal-Fernandez, 2019, Respiratory medicine.

Exploration of the MUC5B promoter variant and ILD risk in patients with autoimmune myositis.

A. Mammen, M. Horton, T. Lloyd, 2017, Respiratory medicine.

Assessment of Mortality in Autoimmune Myositis With and Without Associated Interstitial Lung Disease

A. Mammen, J. Albayda, I. Pinal-Fernandez, 2016, Lung.

Clinical and pathologic differences in interstitial lung disease based on antisynthetase antibody type.

A. Mammen, N. Lechtzin, S. Danoff, 2014, Respiratory Medicine.

Anti–Melanoma Differentiation–Associated Protein 5–Associated Dermatomyositis: Expanding the Clinical Spectrum

S. Danoff, John C. Hall, L. Casciola-Rosen, 2013, Arthritis care & research.

Anti‐Cortactin Autoantibodies Are Associated With Key Clinical Features in Adult Myositis But Are Rarely Present in Juvenile Myositis

A. Mammen, J. Albayda, T. Lloyd, 2021, Arthritis & rheumatology.

Essential Components of an Interstitial Lung Disease Clinic

Hyun J. Kim, Joyce S Lee, M. Strek, 2020, Chest.

More prominent muscle involvement in patients with dermatomyositis with anti-Mi2 autoantibodies

A. Mammen, J. Albayda, I. Pinal-Fernandez, 2019, Neurology.

Muscular and extramuscular clinical features of patients with anti-PM/Scl autoantibodies

A. Mammen, J. Albayda, I. Pinal-Fernandez, 2018, Neurology.

Antinuclear Matrix Protein 2 Autoantibodies and Edema, Muscle Disease, and Malignancy Risk in Dermatomyositis Patients

A. Mammen, J. Albayda, I. Pinal-Fernandez, 2017, Arthritis care & research.

A longitudinal cohort study of the anti-synthetase syndrome: increased severity of interstitial lung disease in black patients and patients with anti-PL7 and anti-PL12 autoantibodies

A. Mammen, J. Albayda, I. Pinal-Fernandez, 2017, Rheumatology.

Long-term treatment with azathioprine and mycophenolate mofetil for myositis-related interstitial lung disease.

A. Mammen, J. Albayda, I. Pinal-Fernandez, 2019, Chest.

Interstitial Lung Disease in Polymyositis and Dermatomyositis.

S. Danoff, K. Long, 2019, Clinics in chest medicine.

Treatment of Interstitial Lung Disease Associated With Myositis and the Anti-Synthetase Syndrome

S. Danoff, R. Hallowell, 2018, Current Treatment Options in Rheumatology.

Pulmonary Manifestations of Polymyositis/Dermatomyositis

S. Danoff, R. Hallowell, D. Ascherman, 2014, Seminars in Respiratory and Critical Care Medicine.

Interstitial Lung Disease in Idiopathic Inflammatory Myopathy.

V. Cottin, L. Saketkoo, C. Oddis, 2010, Current rheumatology reviews.

Steroid-refractory PD-(L)1 pneumonitis: incidence, clinical features, treatment, and outcomes

C. Lin, P. Illei, J. Feliciano, 2021, Journal for ImmunoTherapy of Cancer.

Symptom Management in Advanced Lung Disease

S. Danoff, R. A. Gersten, 2021, Respiratory Medicine.

The Role of Surgical Lung Biopsy in the Diagnosis of Fibrotic Interstitial Lung Disease: Perspective from the Pulmonary Fibrosis Foundation.

Jonathan H. Chung, D. Lynch, L. Hariri, 2021, Annals of the American Thoracic Society.

The telemedicine experience: using principles of clinical excellence to identify disparities and optimize care

R. Llinas, E. Marsh, S. Danoff, 2022, Medicine.

Patient Perspectives in OMERACT Provide an Anchor for Future Metric Development and Improved Approaches to Healthcare Delivery in Connective Tissue Disease Related Interstitial Lung Disease (CTD-ILD).

Ami A. Shah, A. Orbai, V. Strand, 2015, Current respiratory medicine reviews.

The Design and Rationale of the Trail1 Trial: A Randomized Double-Blind Phase 2 Clinical Trial of Pirfenidone in Rheumatoid Arthritis-Associated Interstitial Lung Disease

M. Kolb, I. Rosas, S. Hurwitz, 2019, Advances in Therapy.

Autoantibodies to Peptidylarginine Deiminase 2 Are Associated With Less Severe Disease in Rheumatoid Arthritis

Ryan L. Davis, M. Konig, Hong Wang, 2018, Front. Immunol..

The alveolar immune cell landscape is dysregulated in checkpoint inhibitor pneumonitis.

C. Lin, D. Ettinger, L. Yarmus, 2019, The Journal of clinical investigation.

Safety, tolerability, and efficacy of pirfenidone in patients with rheumatoid arthritis-associated interstitial lung disease: a randomised, double-blind, placebo-controlled, phase 2 study.

G. Raghu, M. Scholand, J. Albayda, 2022, The Lancet. Respiratory medicine.

Longitudinal Course of Disease in a Large Cohort of Myositis Patients With Autoantibodies Recognizing the Signal Recognition Particle

A. Mammen, J. Albayda, I. Pinal-Fernandez, 2017, Arthritis care & research.

Myositis Autoantibodies: A Comparison of Results From the Oklahoma Medical Research Foundation Myositis Panel to the Euroimmun Research Line Blot

A. Mammen, J. Albayda, I. Pinal-Fernandez, 2020, Arthritis & rheumatology.

Anti-mitochondrial autoantibodies are associated with cardiomyopathy, dysphagia, and features of more severe disease in adult-onset myositis

A. Mammen, J. Albayda, T. Lloyd, 2021, Clinical Rheumatology.

Pleuropulmonary disease due to pergolide use for restless legs syndrome.

M. Grasso, S. Danoff, P. Terry, 2001, Chest.

Inflammatory Myopathy/Anti synthetase Syndrome

C. Oddis, S. Danoff, Cheilonda R Johnson, 2014 .

Chronic immune checkpoint inhibitor pneumonitis

C. Lin, J. Taube, L. Yarmus, 2020, Journal for immunotherapy of cancer.

The Genetics of Pulmonary Fibrosis

S. Danoff, Cheilonda R Johnson, Cheilonda Johnson, 2014 .

Interstitial lung disease and sleep: What is known?

N. Collop, H. Schneider, S. Danoff, 2009, Sleep medicine.

Myositis-Associated Interstitial Lung Disease

S. Danoff, 2019, Managing Myositis.

Rebuttal From Drs Yarmus and Danoff.

L. Yarmus, S. Danoff, 2019, Chest.

Sonographic findings from inflammatory arthritis due to antisynthetase syndrome

J. Albayda, C. Bingham, John B Miller, 2019, Clinical rheumatology.

MUC5B Promoter Variant Is Not Associated With Myositis-Related Interstitial Lung Disease

A. Mammen, M. Horton, T. Lloyd, 2012 .

The effect of cigarette smoking on the clinical and serological phenotypes of polymyositis and dermatomyositis.

A. Mammen, S. Adams, E. Shamim, 2018, Seminars in arthritis and rheumatism.

The Impact of Cigarette Smoking on the Clinical and Serological Phenotypes of Polymyositis and Dermatomyositis

A. Mammen, S. Adams, E. Shamim, 2018 .

Interstitial lung disease associated with the idiopathic inflammatory myopathies and the antisynthetase syndrome: recent advances

S. Danoff, R. Hallowell, 2014, Current opinion in rheumatology.

Coexisting autoantibodies against transcription factor Sp4 are associated with decreased cancer risk in patients with dermatomyositis with anti-TIF1γ autoantibodies

A. Mammen, J. Albayda, T. Lloyd, 2022, Annals of the Rheumatic Diseases.

Statin-Induced Anti-HMGCR-Associated Myopathy.

A. Mammen, J. Albayda, T. Lloyd, 2016, Journal of the American College of Cardiology.

Cytosolic 5′‐Nucleotidase 1A As a Target of Circulating Autoantibodies in Autoimmune Diseases

A. Mammen, M. Petri, T. Lloyd, 2015, Arthritis care & research.

Is histamine potentiation of adenosine-stimulated cyclic AMP accumulation in guinea-pig cerebral cortical slices mediated by products of inositol phospholipid breakdown?

J. Young, S. Danoff, 1987, Biochemical pharmacology.

Vascular Endothelial Growth Factor Receptor-2

S. Desiderio, H. Taylor, S. Danoff, 2005, Journal of Biological Chemistry.

The lung as a possible target for the immune reaction in myositis

S. Danoff, L. Casciola-Rosen, L. Casciola‐Rosen, 2011, Arthritis research & therapy.

A North American Cohort of Anti‐SAE Dermatomyositis: Clinical Phenotype, Testing, and Review of Cases

A. Mammen, C. Lin, J. Albayda, 2021, ACR open rheumatology.

Inositol 1,4,5-trisphosphate receptors: distinct neuronal and nonneuronal forms derived by alternative splicing differ in phosphorylation.

S. Snyder, A. Ullrich, C. Ross, 1991, Proceedings of the National Academy of Sciences of the United States of America.

“Hiker’s feet”: a novel cutaneous finding in the inflammatory myopathies

A. Mammen, J. Albayda, D. Gullotti, 2017, Clinical Rheumatology.

Pathology of the lung in myositis

S. Danoff, L. Casciola-Rosen, 2011 .

Molecular cloning of a cDNA for the human inositol 1,4,5-trisphosphate receptor type 1, and the identification of a third alternatively spliced variant.

A. Ullrich, C. Ross, F. Nucifora, 1995, Brain research. Molecular brain research.

Solubilization and separation of inositol 1,3,4,5-tetrakisphosphate- and inositol 1,4,5-trisphosphate-binding proteins and metabolizing enzymes in rat brain.

S. Snyder, S. Supattapone, A. Theibert, 1990, The Biochemical journal.

Cyclic AMP-dependent phosphorylation of a brain inositol trisphosphate receptor decreases its release of calcium.

S. Snyder, S. Supattapone, A. Theibert, 1988, Proceedings of the National Academy of Sciences of the United States of America.

Characterization of a membrane protein from brain mediating the inhibition of inositol 1,4,5-trisphosphate receptor binding by calcium.

S. Snyder, S. Supattapone, S. Danoff, 1988, The Biochemical journal.

Thigh muscle MRI in immune-mediated necrotising myopathy: extensive oedema, early muscle damage and role of anti-SRP autoantibodies as a marker of severity

A. Mammen, J. Carrino, J. Albayda, 2016, Annals of the rheumatic diseases.

Immune Checkpoint Immunotherapy for Non-Small Cell Lung Cancer: Benefits and Pulmonary Toxicities.

C. Lin, J. Naidoo, K. Suresh, 2018, Chest.

Lung transplantation in telomerase mutation carriers with pulmonary fibrosis

P. Shah, J. Orens, M. Arcasoy, 2014, European Respiratory Journal.

Management of interstitial lung disease associated with connective tissue disease

S. Mathai, S. Danoff, 2016, BMJ : British Medical Journal.

Pulmonary Manifestations of Sjögren’s Syndrome

G. Stojan, A. Baer, S. Danoff, 2013, Current Allergy and Asthma Reports.

TFII-I, a candidate gene for Williams syndrome cognitive profile: parallels between regional expression in mouse brain and human phenotype

S. Blackshaw, H. Taylor, S. Danoff, 2004, Neuroscience.

Thalidomide for the Treatment of Cough in Idiopathic Pulmonary Fibrosis

K. Horton, M. Horton, M. Liu, 2012, Annals of Internal Medicine.

Cancer spectrum and outcomes in the Mendelian short telomere syndromes.

Lisa M Haley, A. Blackford, A. Duffield, 2020, Blood.

Diagnosis of Hypersensitivity Pneumonitis in Adults. An Official ATS/JRS/ALAT Clinical Practice Guideline

Jonathan H. Chung, G. Raghu, A. Nicholson, 2020, American journal of respiratory and critical care medicine.

Pneumocystis jirovecii Pneumonia and Other Infections in Idiopathic Inflammatory Myositis

S. Danoff, C. Mecoli, 2020, Current Rheumatology Reports.

Interstitial lung disease associated with the idiopathic inflammatory myopathies: what progress has been made in the past 35 years?

C. Oddis, S. Danoff, L. Christopher‐Stine, 2010, Chest.

A roadmap to promote clinical and translational research in rheumatoid arthritis-associated interstitial lung disease.

H. Collard, E. Matteson, K. Brown, 2014, Chest.

The inositol trisphosphate receptor gene family: Implications for normal and abnormal brain function

C. Ross, S. Danoff, 1994, Progress in Neuro-Psychopharmacology and Biological Psychiatry.

Symptom‐based management of the idiopathic interstitial pneumonia

S. Danoff, B. Garibaldi, 2016, Respirology.

IDIOPATHIC INTERSTITIAL PNEUMONIA — PART 3 : GENERAL MANAGEMENT

S. Danoff, B. Garibaldi, 2015 .

Role of support measures and palliative care

S. Danoff, E. Schonhoft, 2013, Current opinion in pulmonary medicine.

Risk factors for mortality and mortality rates in interstitial lung disease patients in the intensive care unit

R. Brower, S. Danoff, E. Wilfong, 2018, European Respiratory Review.

Connective tissue disease related interstitial lung diseases and idiopathic pulmonary fibrosis: provisional core sets of domains and instruments for use in clinical trials

Ami A. Shah, R. Hubbard, W. Dixon, 2013, Thorax.

Rapidly progressive interstitial lung disease in patients with anti-melanoma differentiation-associated gene 5-positive dermatomyositis: serial changes on HRCT

C. Lin, P. Illei, J. Albayda, 2022, Emergency Radiology.

Rheumatoid arthritis causing diffuse alveolar haemorrhage: a novel therapeutic approach

P. Galiatsatos, S. Bose, S. Danoff, 2017, BMJ Case Reports.

Patient-centered Outcomes Research in Interstitial Lung Disease: An Official American Thoracic Society Research Statement

F. Martinez, G. Raghu, A. Russell, 2021, American journal of respiratory and critical care medicine.

Inositol 1,3,4,5-tetrakisphosphate and inositol hexakisphosphate receptor proteins: isolation and characterization from rat brain.

S. Snyder, G. Prestwich, A. Theibert, 1991, Proceedings of the National Academy of Sciences of the United States of America.

Inositol (1,4,5)-trisphosphate receptor: characterization of neuron-specific alternative splicing in rat brain and peripheral tissues.

C. Ross, M. Schell, S. Danoff, 1993, Brain Research. Molecular Brain Research.

Three additional inositol 1,4,5-trisphosphate receptors: molecular cloning and differential localization in brain and peripheral tissues.

S. Snyder, A. Ullrich, C. Ross, 1992, Proceedings of the National Academy of Sciences of the United States of America.

Nonpharmacologic Therapy for Idiopathic Pulmonary Fibrosis

S. Danoff, L. Silhan, 2017 .

Providing Patient-Centered Care in Interstitial Lung Disease.

S. Danoff, A. Wong, 2021, Clinics in chest medicine.

Burden and Unmet Needs with Portable Oxygen in Patients on Long Term Oxygen Therapy.

S. Acharya, M. Hill, M. McCormack, 2021, Annals of the American Thoracic Society.

Management of Idiopathic Pulmonary Fibrosis in the Elderly Patient: Addressing Key Questions.

S. Nathan, L. Lancaster, K. Meyer, 2015, Chest.

Sleep quality and health-related quality of life in idiopathic pulmonary fibrosis.

M. Horton, N. Collop, M. McCormack, 2008, Chest.

articleRespiratory symptoms and disease characteristics as predictors of pulmonary function abnormalities in patients with rheumatoid arthritis : an observational cohort study

D. Pappas, N. Lechtzin, J. Bathon, 2015 .

Respiratory symptoms and disease characteristics as predictors of pulmonary function abnormalities in patients with rheumatoid arthritis: an observational cohort study

D. Pappas, N. Lechtzin, J. Bathon, 2010, Arthritis research & therapy.

Pirfenidone-induced hyponatraemia: insight in mechanism, risk factor and management

P. Galiatsatos, S. Danoff, L. Silhan, 2017, BMJ Case Reports.

Transbronchial Cryobiopsy for the Diagnosis of Interstitial Lung Diseases: CHEST Guideline and Expert Panel Report.

M. Wahidi, L. Yarmus, J. Hetzel, 2019, Chest.

A Novel Dermato-Pulmonary Syndrome Associated With MDA-5 Antibodies: Report of 2 Cases and Review of the Literature

A. Orbai, A. Rosen, D. Fiorentino, 2012, Medicine.

Presence and Implications of Anti‐Angiotensin Converting Enzyme‐2 Immunoglobulin M Antibodies in Anti‐Melanoma‐Differentiation‐Associated 5 Dermatomyositis

C. Lin, A. Rosen, M. Kuwana, 2022, ACR open rheumatology.

TETHERED IP3. SYNTHESIS AND BIOCHEMICAL APPLICATIONS OF THE 1-O-(3-AMINOPROPYL) ESTER OF INOSITOL 1,4,5-TRISPHOSPHATE

S. Snyder, G. Prestwich, R. Mourey, 1991 .

Performance of the 2017 European Alliance of Associations for Rheumatology/American College of Rheumatology Classification Criteria for Idiopathic Inflammatory Myopathies in Patients With Myositis‐Specific Autoantibodies

A. Mammen, J. Albayda, T. Lloyd, 2022 .

A Standardized Diagnostic Ontology for Fibrotic Interstitial Lung Disease. An International Working Group Perspective

D. Lynch, H. Collard, F. Martinez, 2017, American journal of respiratory and critical care medicine.

ACR Appropriateness Criteria® Diffuse Lung Disease.

Jonathan H. Chung, J. Kanne, B. Carter, 2021, Journal of the American College of Radiology : JACR.

Progressive pulmonary fibrosis: an expert group consensus statement

K. Brown, K. Flaherty, A. Wells, 2022, European Respiratory Journal.

ACR Appropriateness Criteria Diffuse Lung Disease Expert Panel on Thoracic Imaging :

Jonathan H. Chung, J. Kanne, B. Carter, 2022 .

Association of Cross-Reactive Antibodies Targeting Peptidyl-Arginine Deiminase 3 and 4 with Rheumatoid Arthritis-Associated Interstitial Lung Disease

A. Rosen, J. Bathon, S. Danoff, 2014, PloS one.

Association of fine specificity and repertoire expansion of anticitrullinated peptide antibodies with rheumatoid arthritis associated interstitial lung disease

R. Winchester, S. Siegelman, W. Robinson, 2013, Annals of the rheumatic diseases.

Rebuttal From Drs Oldham and Danoff.

S. Danoff, Justin M Oldham, 2019, Chest.

COUNTERPOINT: Does Interstitial Pneumonia With Autoimmune Features Represent a Distinct Class of Patients With Idiopathic Interstitial Pneumonia? No.

S. Danoff, J. Oldham, Justin M Oldham, 2019, Chest.

Myositis: Prognostic factors in 'pneumo-myositis'

S. Danoff, 2018, Nature Reviews Rheumatology.

Ziritaxestat, a Novel Autotaxin Inhibitor, and Lung Function in Idiopathic Pulmonary Fibrosis: The ISABELA 1 and 2 Randomized Clinical Trials.

G. Molenberghs, M. Kreuter, A. Taneja, 2023, JAMA.

Diagnosis of Idiopathic Pulmonary Fibrosis An Of fi cial ATS / ERS / JRS / ALAT Clinical Practice Guideline : Executive Summary

H. Collard, F. Martinez, G. Raghu, 2018 .

Smoking and Subclinical ILD in RA versus the Multi-Ethnic Study of Atherosclerosis

E. Hoffman, R. Barr, J. Bathon, 2016, PloS one.

Intravenous Immunoglobulin as Potential Adjunct Therapy for Interstitial Lung Disease.

S. Danoff, R. Hallowell, D. Amariei, 2016, Annals of the American Thoracic Society.

Efficacy and adverse effects of methotrexate compared with azathioprine in the antisynthetase syndrome.

A. Mammen, J. Albayda, I. Pinal-Fernandez, 2019, Clinical and experimental rheumatology.

Diagnostic Delays in Interstitial Lung Diseases (ILDs)

S. Danoff, C. Valenzuela, B. Mounir, 2019, Diagnosis.

Clinical Subgroups and Factors Associated With Progression in Patients With Inclusion Body Myositis

A. Mammen, J. Albayda, T. Lloyd, 2023, Neurology.

The inositol trisphosphate receptor: A potpourri of second-messenger regulation

S. Snyder, P. Worley, J. Baraban, 1988, Cellular and Molecular Neurobiology.

Provider Perspectives on and Access to Palliative Care for Patients with Interstitial Lung Disease.

K. Lindell, B. Seth, S. Danoff, 2022, Chest.

Pulmonary impairment, not muscle injury, is associated with elevated ESR in the idiopathic inflammatory myopathies.

J. Park, A. Gelber, S. Danoff, 2013, Rheumatology.

Cyclic AMP-dependent phosphorylation of a brain inositol trisphosphate receptor decreases its release of calcium.

S. Supattapone, A. Theibert, S. Danoff, 1988, Proceedings of the National Academy of Sciences of the United States of America.

Connective tissue disease related interstitial lung diseases and idiopathic pulmonary fibrosis: provisional core sets of domains and instruments for use in clinical trials

Ami A. Shah, R. Hubbard, W. Dixon, 2013, Thorax.

The alveolar immune cell landscape is dysregulated in checkpoint inhibitor pneumonitis.

C. Lin, D. Ettinger, L. Yarmus, 2019, The Journal of clinical investigation.

International Guideline for Idiopathic Inflammatory Myopathy-Associated Cancer Screening: an International Myositis Assessment and Clinical Studies Group (IMACS) initiative

A. Mammen, H. Mann, L. Saketkoo, 2023, Nature Reviews Rheumatology.

Antinuclear Matrix Protein 2 Autoantibodies and Edema, Muscle Disease, and Malignancy Risk in Dermatomyositis Patients

A. Mammen, J. Albayda, I. Pinal-Fernandez, 2017, Arthritis care & research.

Subsets of Idiopathic Inflammatory Myositis Enriched for Contemporaneous Cancer Relative to the General Population

Ami A. Shah, A. Mammen, E. Platz, 2022, Arthritis & rheumatology.

Long-term treatment with human immunoglobulin for antisynthetase syndrome-associated interstitial lung disease.

A. Mammen, C. Lin, J. Albayda, 2019, Respiratory medicine.

A. Mammen, J. Albayda, T. Lloyd, 2021, Arthritis & rheumatology.

Panel on Thoracic Imaging: Stephen